Free Trial

DRI Healthcare Trust (DHT.UN) Competitors

DRI Healthcare Trust logo
C$12.65 +0.08 (+0.64%)
As of 01:36 PM Eastern

DHT.UN vs. ATT, AGRA, MJ, BIO, BBM, BAMM, LOVE, CSI, CALI, and DCNN

Should you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Abattis Bioceuticals (ATT), Agraflora Organics International (AGRA), Amplify Alternative Harvest ETF (MJ), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), BooksAMillion (BAMM), Cannara Biotech (LOVE), Chemesis International (CSI), China Auto Logistics (CALI), and Digicann Ventures (DCNN). These companies are all part of the "drug manufacturers - specialty & generic" industry.

DRI Healthcare Trust vs.

Abattis Bioceuticals (CNSX:ATT) and DRI Healthcare Trust (TSE:DHT.UN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

DRI Healthcare Trust has a net margin of 5.02% compared to Abattis Bioceuticals' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Abattis Bioceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Abattis BioceuticalsN/A N/A N/A
DRI Healthcare Trust 5.02%2.06%4.22%

DRI Healthcare Trust has higher revenue and earnings than Abattis Bioceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
DRI Healthcare TrustC$193.66MN/AC$9.73M-C$0.05-253.00

Abattis Bioceuticals received 65 more outperform votes than DRI Healthcare Trust when rated by MarketBeat users. However, 80.00% of users gave DRI Healthcare Trust an outperform vote while only 64.89% of users gave Abattis Bioceuticals an outperform vote.

CompanyUnderperformOutperform
Abattis BioceuticalsOutperform Votes
85
64.89%
Underperform Votes
46
35.11%
DRI Healthcare TrustOutperform Votes
20
80.00%
Underperform Votes
5
20.00%

In the previous week, DRI Healthcare Trust had 4 more articles in the media than Abattis Bioceuticals. MarketBeat recorded 4 mentions for DRI Healthcare Trust and 0 mentions for Abattis Bioceuticals. DRI Healthcare Trust's average media sentiment score of 1.00 beat Abattis Bioceuticals' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Abattis Bioceuticals Neutral
DRI Healthcare Trust Positive

48.4% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DRI Healthcare Trust has a consensus price target of C$18.07, indicating a potential upside of 42.86%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Abattis Bioceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abattis Bioceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DRI Healthcare Trust
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

DRI Healthcare Trust beats Abattis Bioceuticals on 12 of the 13 factors compared between the two stocks.

Get DRI Healthcare Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHT.UN vs. The Competition

MetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapN/AC$2.17BC$5.33BC$5.95B
Dividend Yield3.26%2.92%5.20%6.32%
P/E Ratio-253.003.9726.7429.43
Price / SalesN/A569.72394.49943.42
Price / CashN/A10.2538.3283.71
Price / Book1.366.956.743.99
Net IncomeC$9.73MC$20.70BC$3.23BC$301.32M
7 Day Performance0.32%-0.44%0.13%0.82%
1 Month Performance12.85%3.33%8.83%6.81%
1 Year Performance-14.64%96.02%18.45%17.18%

DRI Healthcare Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHT.UN
DRI Healthcare Trust
1.7672 of 5 stars
C$12.65
+0.6%
C$18.07
+42.9%
-13.8%C$0.00C$193.66M-253.00N/AAnalyst Forecast
ATT
Abattis Bioceuticals
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Up
AGRA
Agraflora Organics International
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
MJ
Amplify Alternative Harvest ETF
N/AN/AN/AN/A$0.00N/A0.007News Coverage
Gap Up
BIO
Bio-Rad Laboratories
N/AN/AN/AN/A$0.00N/A0.008,000High Trading Volume
BBM
Blueberries Medical
N/AN/AN/AN/A$0.00N/A0.008High Trading Volume
BAMM
BooksAMillion
N/AN/AN/AN/A$0.00N/A0.00142News Coverage
High Trading Volume
LOVE
Cannara Biotech
N/AN/AN/AN/A$0.00N/A0.00N/APositive News
High Trading Volume
CSI
Chemesis International
N/AN/AN/AN/A$0.00N/A0.00147,000Gap Down
High Trading Volume
CALI
China Auto Logistics
N/AN/AN/AN/A$0.00N/A0.0040Gap Down
High Trading Volume
DCNN
Digicann Ventures
N/AN/AN/AN/A$0.00N/A0.00N/A

Related Companies and Tools


This page (TSE:DHT.UN) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners